IL6 and cancer: The classical and alternative IL-6 signaling pathways activate JAKs with subsequent activation of the signal transducer and activator of transcription-3 (STAT3), a key transcription factor inducing numerous effector genes involved in cancer promotion and malignancy [18,19,20].